<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01754207</url>
  </required_header>
  <id_info>
    <org_study_id>CYN11-PICO-D-A-TAT</org_study_id>
    <nct_id>NCT01754207</nct_id>
  </id_info>
  <brief_title>Evaluation of the 755nm Alexandrite Laser for the Treatment of Tattoos</brief_title>
  <official_title>Evaluation of the 755nm Alexandrite Laser for the Treatment of Tattoos</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Cynosure, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Cynosure, Inc.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to collect further data on the safety and efficacy of removing
      unwanted non cosmetic tattoos (including recalcitrant) using the 755nm Alexandrite laser.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>December 2011</start_date>
  <completion_date type="Actual">January 2014</completion_date>
  <primary_completion_date type="Actual">January 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Photographic Evaluation</measure>
    <time_frame>up to 3 months post last treatment</time_frame>
    <description>2D photography comparing pre and post treatment results</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">20</enrollment>
  <condition>Tattoos</condition>
  <arm_group>
    <arm_group_label>755nm Alexandrite Laser</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>755nm Alexandrite Laser</description>
  </arm_group>
  <arm_group>
    <arm_group_label>755nm Alexandrite Laser with CAP Array</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>755nm Alexandrite Laser with CAP Array</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>755nm Alexandrite Laser</intervention_name>
    <description>755nm Alexandrite Laser</description>
    <arm_group_label>755nm Alexandrite Laser</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>755nm Alexandrite Laser with CAP Array</intervention_name>
    <description>755nm Alexandrite Laser with CAP Array</description>
    <arm_group_label>755nm Alexandrite Laser with CAP Array</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Is a healthy male or female between 18 and 85 years old.

          2. Has unwanted non-cosmetic tattoo(s) and wishes to undergo laser treatments to remove
             them.

          3. Is willing to consent to participate in the study.

          4. Is willing to comply with all requirements of the study including being photographed,
             following post treatment care and attending all treatment and follow up visits

        Exclusion Criteria:

          1. Is hypersensitive to light exposure.

          2. Has active localized or systemic infection.

          3. Is taking medication(s) for which sunlight is a contraindication.

          4. Has a history of squamous cell carcinoma or melanoma.

          5. Has a history of keloid scarring.

          6. Has used oral isotretinoin (AccutaneÂ®) within 12 months of initial treatment or plans
             on using during the course of the study. Note: Skin must regain its normal degree of
             moisture prior to treatment.

          7. Has a history of immunosuppression/immune deficiency disorders (including HIV
             infection or AIDS) or use of immunosuppressive medications.

          8. Is female and pregnant, has been pregnant within the last 3 months, is currently
             breast feeding or planning a pregnancy during the study period.

          9. Is allergic to lidocaine, tetracaine or Xylocaine with epinephrine.

         10. Has any other reason determined by the physician to be ineligible to participate in
             the study.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Patricia Krantz</last_name>
    <role>Study Director</role>
    <affiliation>Cynosure, Inc.</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Skin Care Physicians</name>
      <address>
        <city>Chestnut Hill</city>
        <state>Massachusetts</state>
        <zip>02467</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>February 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 18, 2012</study_first_submitted>
  <study_first_submitted_qc>December 18, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 21, 2012</study_first_posted>
  <last_update_submitted>February 7, 2014</last_update_submitted>
  <last_update_submitted_qc>February 7, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 10, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

